Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

24 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Correction: Alvarado-Miranda et al. Capecitabine Plus Aromatase Inhibitor as First Line Therapy for Hormone Receptor Positive, HER2 Negative Metastatic Breast Cancer. Curr. Oncol. 2023, 30, 6097-6110.
Alvarado-Miranda A, Lara-Medina FU, Muñoz-Montaño WR, Zinser-Sierra JW, Galeana PAC, Garza CV, Sanchez Benitez D, Limón Rodríguez JA, Arce Salinas CH, Guijosa A, Arrieta O. Alvarado-Miranda A, et al. Curr Oncol. 2024 Nov 15;31(11):7177-7179. doi: 10.3390/curroncol31110529. Curr Oncol. 2024. PMID: 39590178 Free PMC article.
Capecitabine Plus Aromatase Inhibitor as First Line Therapy for Hormone Receptor Positive, HER2 Negative Metastatic Breast Cancer.
Alvarado-Miranda A, Lara-Medina FU, Muñoz-Montaño WR, Zinser-Sierra JW, Galeana PAC, Garza CV, Sanchez Benitez D, Limón Rodríguez JA, Arce Salinas CH, Guijosa A, Arrieta O. Alvarado-Miranda A, et al. Curr Oncol. 2023 Jun 24;30(7):6097-6110. doi: 10.3390/curroncol30070454. Curr Oncol. 2023. PMID: 37504314 Free PMC article.
Pathogenic variant profile in DNA damage response genes correlates with metastatic breast cancer progression-free survival in a Mexican-mestizo population.
Vázquez-Romo R, Millan-Catalan O, Ruíz-García E, Martínez-Gutiérrez AD, Alvarado-Miranda A, Campos-Parra AD, López-Camarillo C, Jacobo-Herrera N, López-Urrutia E, Guardado-Estrada M, Cantú de León D, Pérez-Plasencia C. Vázquez-Romo R, et al. Among authors: alvarado miranda a. Front Oncol. 2023 Apr 27;13:1146008. doi: 10.3389/fonc.2023.1146008. eCollection 2023. Front Oncol. 2023. PMID: 37182128 Free PMC article.
Prognosis of breast cancer diagnosed during pregnancy and early postpartum according to immunohistochemical subtype: A matched case-control study.
Muñoz-Montaño WR, Cabrera-Galeana P, De la Garza-Ramos C, Azim HA Jr, Tabares A, Perez V, Porras Reyes F, Sanchez Benitez D, Alvarado-Miranda A, Lara-Medina F, Vazquez Romo R, Bargallo-Rocha E, Arrieta O, Villarreal-Garza C. Muñoz-Montaño WR, et al. Among authors: alvarado miranda a. Breast Cancer Res Treat. 2021 Jul;188(2):489-500. doi: 10.1007/s10549-021-06225-4. Epub 2021 Jun 16. Breast Cancer Res Treat. 2021. PMID: 34132938
Identification of risk factors for central nervous system metastasis in patients with breast cancer with neurologic symptoms.
Cacho-Díaz B, Salmerón-Moreno K, Alvarez-Alvarez A, Mendoza-Olivas LG, Alvarado-Miranda A, Villarreal-Garza C, Reynoso-Noverón N, Chávez-MacGregor M, Meneses-García AA. Cacho-Díaz B, et al. Among authors: alvarado miranda a. Cancer. 2020 Aug 1;126(15):3456-3463. doi: 10.1002/cncr.32928. Epub 2020 May 26. Cancer. 2020. PMID: 32453447 Free article.
Prognostic Value of the Pretreatment Neutrophil-to-Lymphocyte Ratio in Different Phenotypes of Locally Advanced Breast Cancer During Neoadjuvant Systemic Treatment.
Muñoz-Montaño W, Cabrera-Galeana P, Alvarado-Miranda A, Villarreal-Garza C, Mohar A, Olvera A, Bargallo-Rocha E, Lara-Medina F, Arrieta O. Muñoz-Montaño W, et al. Among authors: alvarado miranda a. Clin Breast Cancer. 2020 Aug;20(4):307-316.e1. doi: 10.1016/j.clbc.2019.12.011. Epub 2020 Jan 21. Clin Breast Cancer. 2020. PMID: 32305297
Real-World Outcomes Among Older Mexican Women with Breast Cancer Treated with Neoadjuvant Chemotherapy.
Cabrera-Galeana P, Soto-Perez-de-Celis E, Reynoso-Noveron N, Villarreal-Garza C, Lara-Medina F, Alvarado-Miranda A, Espinosa-Fernandez JR, Esparza-Arias N, Mohar A, Bargallo-Rocha JE. Cabrera-Galeana P, et al. Among authors: alvarado miranda a. Oncologist. 2020 Dec;25(12):1023-1031. doi: 10.1634/theoncologist.2019-0891. Epub 2020 Apr 28. Oncologist. 2020. PMID: 32275801 Free PMC article.
miRNA profile obtained by next‑generation sequencing in metastatic breast cancer patients is able to predict the response to systemic treatments.
Martinez-Gutierrez AD, Catalan OM, Vázquez-Romo R, Porras Reyes FI, Alvarado-Miranda A, Lara Medina F, Bargallo-Rocha JE, Orozco Moreno LT, Cantú De León D, Herrera LA, López-Camarillo C, Pérez-Plasencia C, Campos-Parra AD. Martinez-Gutierrez AD, et al. Among authors: alvarado miranda a. Int J Mol Med. 2019 Oct;44(4):1267-1280. doi: 10.3892/ijmm.2019.4292. Epub 2019 Jul 30. Int J Mol Med. 2019. PMID: 31364724 Free PMC article.
Effects of omega-3 fatty acids supplementation on neoadjuvant chemotherapy-induced toxicity in patients with locally advanced breast cancer: a randomized, controlled, double-blinded clinical trial.
de la Rosa Oliva F, Meneses García A, Ruiz Calzada H, Astudillo de la Vega H, Bargalló Rocha E, Lara-Medina F, Alvarado Miranda A, Matus-Santos J, Flores-Díaz D, Oñate-Acuña LF, Gutiérrez-Salmeán G, Ruiz García E, Ibarra A. de la Rosa Oliva F, et al. Among authors: alvarado miranda a. Nutr Hosp. 2019 Aug 26;36(4):769-776. doi: 10.20960/nh.2338. Nutr Hosp. 2019. PMID: 31192682 Free article. Clinical Trial. English.
24 results